Результаты поиска - Renzo Galanello

Отмена результатов
  1. 1
    Renal aspects of thalassaemia a changing paradigm

    Renal aspects of thalassaemia a changing paradigm по Sunil Bhandari, Renzo Galanello

    Опубликовано 2012
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Relationship between Genotype and Phenotype: Thalassemia Intermedia<sup>a</sup>

    Relationship between Genotype and Phenotype: Thalassemia Intermedia<sup>a</sup> по Renzo Galanello, Antonio Cao

    Опубликовано 1998
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Beta-thalassemia

    Beta-thalassemia по Renzo Galanello, Raffaella Origa

    Опубликовано 2010
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  4. 4
    Beta-thalassemia

    Beta-thalassemia по Antonio Cao, Renzo Galanello

    Опубликовано 2010
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  5. 5
    8 Prenatal diagnosis and screening of the haemoglobinopathies

    8 Prenatal diagnosis and screening of the haemoglobinopathies по Antonio Cao, Renzo Galanello, Maria Cristina Rosatelli

    Опубликовано 1998
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  6. 6
    Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

    Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone по Alan R. Cohen, Renzo Galanello, Antonio Piga, Vincenzo De Sanctis, Fernando Tricta

    Опубликовано 2003
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Thalassemia

    Thalassemia по Alan R. Cohen, Renzo Galanello, Dudley J. Pennell, Melody J. Cunningham, Elliott Vichinsky

    Опубликовано 2004
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  8. 8
    Deferiprone‐induced agranulocytosis: 20 years of clinical observations

    Deferiprone‐induced agranulocytosis: 20 years of clinical observations по Fernando Tricta, Jack Uetrecht, Renzo Galanello, John T. Connelly, Anna Rozova, Michael Spino, Jan Palmblad

    Опубликовано 2016
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Efficacy and safety of deferasirox doses of &gt;30 mg/kg per d in patients with transfusion‐dependent anaemia and iron overload

    Efficacy and safety of deferasirox doses of &gt;30 mg/kg per d in patients with transfusion‐dependent anaemia and iron overload по Alì Taher, Maria Domenica Cappellini, Elliott Vichinsky, Renzo Galanello, Antonio Piga, Tomasz Lawniczek, Joan Clark, Dany Habr, John B. Porter

    Опубликовано 2009
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  10. 10
    KLF1 gene mutations cause borderline HbA2

    KLF1 gene mutations cause borderline HbA2 по Lucia Perseu, Stefania Satta, Paolo Moi, Franca Rosa Demartis, Laura Manunza, Maria Carla Sollaino, Susanna Barella, Antonio Cao, Renzo Galanello

    Опубликовано 2011
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction

    Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction по Mark Tanner, Renzo Galanello, Carlo Dessì, Gillian Smith, Mark A. Westwood, Annalisa Agus, Martina Pibiri, Sunil V. Nair, John M. Walker, Dudley J. Pennell

    Опубликовано 2008
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies

    EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies по Joanne Traeger‐Synodinos, Cornelis L. Harteveld, John Old, Mary Petrou, Renzo Galanello, Piero C. Giordano, Michael Angastioniotis, Barbara De la Salle, Shirley Henderson, Alison May

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma

    Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma по Rita Paroni, Ferruccio Ceriotti, Renzo Galanello, Giovan Battista Leoni, Alessandra Panìco, Emanuele Scurati, Renata Paleari, Liliana Chemello, Vania Quaino, Luca Scaldaferri, Annunziata Lapolla, Andrea Mosca

    Опубликовано 2007
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients

    The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients по Adriana Ceci, Paola Baiardi, Mariagrazia Felisi, Maria Domenica Cappellini, V. Carnelli, Vincenzo De Sanctis, Renzo Galanello, Aurelio Maggio, Giuseppe Masera, Antonio Piga, Francesco Schettini, Ippazio Stefàno, Fernando Tricta

    Опубликовано 2002
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization

    Prevalence and Risk Factors for Pulmonary Arterial Hypertension in a Large Group of β-Thalassemia Patients Using Right Heart Catheterization по Giorgio Derchi, Renzo Galanello, Patrizio Bina, Maria Domenica Cappellini, Antonio Piga, Maria-Eliana Lai, Antonella Quarta, Gavino Casu, Silverio Perrotta, Valeria Maria Pinto, Khaled M. Musallam, Gian Luca Forni

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study

    Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study по Alì Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, Noppadol Siritanaratkul, Renzo Galanello, Zeynep Karakaş, Tomasz Lawniczek, Jacqueline Ros, Yiyun Zhang, Dany Habr, Maria Domenica Cappellini

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study

    Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study по Alì Taher, John B. Porter, Vip Viprakasit, Antonis Kattamis, Suporn Chuncharunee, Pranee Sutcharitchan, Noppadol Siritanaratkul, Renzo Galanello, Zeynep Karakaş, Tomasz Lawniczek, Dany Habr, Jacqueline Ros, Zewen Zhu, Maria Domenica Cappellini

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload

    A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overload по Ellis J. Neufeld, Renzo Galanello, Vip Viprakasit, Yeşim Aydınok, Antonio Piga, Paul Harmatz, Gian Luca Forni, Farrukh Shah, Rachael F. Grace, John B. Porter, John C. Wood, Jennifer Peppe, Amber Jones, Hugh Young Rienhoff

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Brazilian Association of Thalassemia protocol for iron chelation therapy in patients under regular transfusion

    Brazilian Association of Thalassemia protocol for iron chelation therapy in patients under regular transfusion по Mônica Pinheiro de Almeida Veríssimo, Sandra Regina Loggetto, Antônio Fabron, Giorgio Roberto Baldanzi, Nelson Hamerschlak, Juliano Lara Fernandes, Aderson da Silva Araújo, Clarisse Lopes de Castro Lobo, Kleber Yotsumoto Fertrin, Vasilios Berdoukas, Renzo Galanello

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Cardiovascular Function and Treatment in β-Thalassemia Major

    Cardiovascular Function and Treatment in β-Thalassemia Major по Dudley J. Pennell, James E. Udelson, Andrew E. Arai, Biykem Bozkurt, Alan R. Cohen, Renzo Galanello, Timothy M. Hoffman, Matthew C. Kiernan, Stamatios Lerakis, Antonio Piga, John B. Porter, John M. Walker, John C. Wood

    Опубликовано 2013
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: